1 Belimumab Market Overview 1.1 Belimumab Product Overview 1.2 Belimumab Market Segment by Type 1.2.1 400mg Injection 1.2.2 120mg Injection 1.3 Global Belimumab Market Size by Type 1.3.1 Global Belimumab Market Size Overview by Type (2016-2027) 1.3.2 Global Belimumab Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Belimumab Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Belimumab Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Belimumab Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Belimumab Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Belimumab Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Belimumab Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Belimumab Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Belimumab Sales Breakdown by Type (2016-2021) 1.4.2 Europe Belimumab Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Belimumab Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Belimumab Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Belimumab Sales Breakdown by Type (2016-2021) 2 Global Belimumab Market Competition by Company 2.1 Global Top Players by Belimumab Sales (2016-2021) 2.2 Global Top Players by Belimumab Revenue (2016-2021) 2.3 Global Top Players Belimumab Price (2016-2021) 2.4 Global Top Manufacturers Belimumab Manufacturing Base Distribution, Sales Area, Product Type 2.5 Belimumab Market Competitive Situation and Trends 2.5.1 Belimumab Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Belimumab Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Belimumab as of 2020) 2.7 Date of Key Manufacturers Enter into Belimumab Market 2.8 Key Manufacturers Belimumab Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Belimumab Status and Outlook by Region 3.1 Global Belimumab Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Belimumab Historic Market Size by Region 3.2.1 Global Belimumab Sales in Volume by Region (2016-2021) 3.2.2 Global Belimumab Sales in Value by Region (2016-2021) 3.2.3 Global Belimumab Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Belimumab Forecasted Market Size by Region 3.3.1 Global Belimumab Sales in Volume by Region (2022-2027) 3.3.2 Global Belimumab Sales in Value by Region (2022-2027) 3.3.3 Global Belimumab Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Belimumab by Application 4.1 Belimumab Market Segment by Application 4.1.1 Hospital 4.1.2 Drug Center 4.1.3 Clinic 4.1.4 Other 4.2 Global Belimumab Market Size by Application 4.2.1 Global Belimumab Market Size Overview by Application (2016-2027) 4.2.2 Global Belimumab Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Belimumab Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Belimumab Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Belimumab Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Belimumab Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Belimumab Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Belimumab Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Belimumab Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Belimumab Sales Breakdown by Application (2016-2021) 4.3.2 Europe Belimumab Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Belimumab Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Belimumab Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Belimumab Sales Breakdown by Application (2016-2021) 5 North America Belimumab by Country 5.1 North America Belimumab Historic Market Size by Country 5.1.1 North America Belimumab Sales in Volume by Country (2016-2021) 5.1.2 North America Belimumab Sales in Value by Country (2016-2021) 5.2 North America Belimumab Forecasted Market Size by Country 5.2.1 North America Belimumab Sales in Volume by Country (2022-2027) 5.2.2 North America Belimumab Sales in Value by Country (2022-2027) 6 Europe Belimumab by Country 6.1 Europe Belimumab Historic Market Size by Country 6.1.1 Europe Belimumab Sales in Volume by Country (2016-2021) 6.1.2 Europe Belimumab Sales in Value by Country (2016-2021) 6.2 Europe Belimumab Forecasted Market Size by Country 6.2.1 Europe Belimumab Sales in Volume by Country (2022-2027) 6.2.2 Europe Belimumab Sales in Value by Country (2022-2027) 7 Asia-Pacific Belimumab by Region 7.1 Asia-Pacific Belimumab Historic Market Size by Region 7.1.1 Asia-Pacific Belimumab Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Belimumab Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Belimumab Forecasted Market Size by Region 7.2.1 Asia-Pacific Belimumab Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Belimumab Sales in Value by Region (2022-2027) 8 Latin America Belimumab by Country 8.1 Latin America Belimumab Historic Market Size by Country 8.1.1 Latin America Belimumab Sales in Volume by Country (2016-2021) 8.1.2 Latin America Belimumab Sales in Value by Country (2016-2021) 8.2 Latin America Belimumab Forecasted Market Size by Country 8.2.1 Latin America Belimumab Sales in Volume by Country (2022-2027) 8.2.2 Latin America Belimumab Sales in Value by Country (2022-2027) 9 Middle East and Africa Belimumab by Country 9.1 Middle East and Africa Belimumab Historic Market Size by Country 9.1.1 Middle East and Africa Belimumab Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Belimumab Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Belimumab Forecasted Market Size by Country 9.2.1 Middle East and Africa Belimumab Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Belimumab Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Belimumab Business 10.1 GlaxoSmithKline 10.1.1 GlaxoSmithKline Corporation Information 10.1.2 GlaxoSmithKline Introduction and Business Overview 10.1.3 GlaxoSmithKline Belimumab Sales, Revenue and Gross Margin (2016-2021) 10.1.4 GlaxoSmithKline Belimumab Products Offered 10.1.5 GlaxoSmithKline Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Belimumab Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Belimumab Industrial Chain Analysis 11.4 Belimumab Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Belimumab Distributors 12.3 Belimumab Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 400mg Injection Table 2. Major Company of 120mg Injection Table 3. Global Belimumab Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Belimumab Sales by Type (2016-2021) & (K Pcs) Table 5. Global Belimumab Sales Market Share in Volume by Type (2016-2021) Table 6. Global Belimumab Sales by Type (2016-2021) & (US& Million) Table 7. Global Belimumab Market Share in Value by Type (2016-2021) Table 8. Global Belimumab Price by Type (2016-2021) & (USD/Pcs) Table 9. Global Belimumab Sales by Type (2022-2027) & (K Pcs) Table 10. Global Belimumab Sales Market Share in Volume by Type (2022-2027) Table 11. Global Belimumab Sales by Type (2022-2027) & (US$ Million) Table 12. Global Belimumab Sales Market Share in Value by Type (2022-2027) Table 13. Global Belimumab Price by Type (2022-2027) & (USD/Pcs) Table 14. North America Belimumab Sales by Type (2016-2021) & (K Pcs) Table 15. North America Belimumab Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Belimumab Sales (K Pcs) by Type (2016-2021) Table 17. Europe Belimumab Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Belimumab Sales (K Pcs) by Type (2016-2021) Table 19. Asia-Pacific Belimumab Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Belimumab Sales (K Pcs) by Type (2016-2021) Table 21. Latin America Belimumab Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Belimumab Sales (K Pcs) by Type (2016-2021) Table 23. Middle East and Africa Belimumab Sales by Type (2016-2021) & (US$ Million) Table 24. Global Belimumab Sales by Company (2016-2021) & (K Pcs) Table 25. Global Belimumab Sales Share by Company (2016-2021) Table 26. Global Belimumab Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Belimumab Revenue Share by Company (2016-2021) Table 28. Global Market Belimumab Price by Company (2016-2021) & (USD/Pcs) Table 29. Global Belimumab Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Belimumab Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Belimumab as of 2020 Table 32. Date of Key Manufacturers Enter into Belimumab Market Table 33. Key Manufacturers Belimumab Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Belimumab Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Belimumab Sales by Region (2016-2021) & (K Pcs) Table 37. Global Belimumab Sales Market Share in Volume by Region (2016-2021) Table 38. Global Belimumab Sales by Region (2016-2021) & (US$ Million) Table 39. Global Belimumab Sales Market Share in Value by Region (2016-2021) Table 40. Global Belimumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 41. Global Belimumab Sales by Region (2022-2027) & (K Pcs) Table 42. Global Belimumab Sales Market Share in Volume by Region (2022-2027) Table 43. Global Belimumab Sales by Region (2022-2027) & (US$ Million) Table 44. Global Belimumab Sales Market Share in Value by Region (2022-2027) Table 45. Global Belimumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 46. Global Belimumab Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Belimumab Sales by Application (2016-2021) & (K Pcs) Table 48. Global Belimumab Sales Market Share in Volume by Application (2016-2021) Table 49. Global Belimumab Sales by Application (2016-2021) & (US$ Million) Table 50. Global Belimumab Sales Market Share in Value by Application (2016-2021) Table 51. Global Belimumab Price by Application (2016-2021) & (USD/Pcs) Table 52. Global Belimumab Sales by Application (2022-2027) & (K Pcs) Table 53. Global Belimumab Sales Market Share in Volume by Application (2022-2027) Table 54. Global Belimumab Sales by Application (2022-2027) & (US$ Million) Table 55. Global Belimumab Sales Market Share in Value by Application (2022-2027) Table 56. Global Belimumab Price by Application (2022-2027) & (USD/Pcs) Table 57. North America Belimumab Sales by Application (2016-2021) (K Pcs) Table 58. North America Belimumab Sales by Application (2016-2021) & (US$ Million) Table 59. North America Belimumab Sales Market Share in Value by Application in 2020 Table 60. Europe Belimumab Sales by Application (2016-2021) (K Pcs) Table 61. Europe Belimumab Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Belimumab Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Belimumab Sales by Application (2016-2021) (K Pcs) Table 64. Asia-Pacific Belimumab Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Belimumab Sales Market Share in Value by Application in 2020 Table 66. Latin America Belimumab Sales by Application (2016-2021) (K Pcs) Table 67. Latin America Belimumab Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Belimumab Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Belimumab Sales by Application (2016-2021) (K Pcs) Table 70. Middle East and Africa Belimumab Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Belimumab Sales Market Share in Value by Application in 2020 Table 72. North America Belimumab Sales by Country (2016-2021) & (K Pcs) Table 73. North America Belimumab Sales Market Share in Volume by Country (2016-2021) Table 74. North America Belimumab Sales by Country (2016-2021) & (US$ Million) Table 75. North America Belimumab Sales Market Share in Value by Country (2016-2021) Table 76. North America Belimumab Sales by Country (2022-2027) & (K Pcs) Table 77. North America Belimumab Sales Market Share in Volume by Country (2022-2027) Table 78. North America Belimumab Sales by Country (2022-2027) & (US$ Million) Table 79. North America Belimumab Sales Market Share in Value by Country (2022-2027) Table 80. Europe Belimumab Sales by Country (2016-2021) & (K Pcs) Table 81. Europe Belimumab Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Belimumab Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Belimumab Sales Market Share in Value by Country (2016-2021) Table 84. Europe Belimumab Sales by Country (2022-2027) & (K Pcs) Table 85. Europe Belimumab Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Belimumab Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Belimumab Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Belimumab Sales by Region (2016-2021) & (K Pcs) Table 89. Asia-Pacific Belimumab Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Belimumab Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Belimumab Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Belimumab Sales by Region (2022-2027) & (K Pcs) Table 93. Asia-Pacific Belimumab Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Belimumab Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Belimumab Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Belimumab Sales by Country (2016-2021) & (K Pcs) Table 97. Latin America Belimumab Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Belimumab Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Belimumab Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Belimumab Sales by Country (2022-2027) & (K Pcs) Table 101. Latin America Belimumab Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Belimumab Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Belimumab Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Belimumab Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa Belimumab Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Belimumab Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Belimumab Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Belimumab Sales by Country (2022-2027) & (K Pcs) Table 109. Middle East and Africa Belimumab Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Belimumab Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Belimumab Sales Market Share in Value by Country (2022-2027) Table 112. GlaxoSmithKline Corporation Information Table 113. GlaxoSmithKline Introduction and Business Overview Table 114. GlaxoSmithKline Belimumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 115. GlaxoSmithKline Belimumab Product Table 116. GlaxoSmithKline Recent Development Table 117. Key Raw Materials Lists Table 118. Raw Materials Key Suppliers Lists Table 119. Belimumab Market Trends Table 120. Belimumab Market Drivers Table 121. Belimumab Market Challenges Table 122. Belimumab Market Restraints Table 123. Belimumab Distributors List Table 124. Belimumab Downstream Customers Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Belimumab Product Picture Figure 2. Global Belimumab Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Belimumab Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Belimumab Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 400mg Injection Figure 6. Global 400mg Injection Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 120mg Injection Figure 8. Global 120mg Injection Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Global Belimumab Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Belimumab Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Belimumab Sales Market Share in Value by Type (2016-2021) Figure 12. Global Belimumab Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Belimumab Sales Market Share in Value by Type (2022-2027) Figure 14. North America Belimumab Sales Market Share in Volume by Type in 2020 Figure 15. North America Belimumab Sales Market Share in Value by Type in 2020 Figure 16. Europe Belimumab Sales Market Share in Volume by Type in 2020 Figure 17. Europe Belimumab Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Belimumab Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Belimumab Sales Market Share in Value by Type in 2020 Figure 20. Latin America Belimumab Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Belimumab Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Belimumab Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Belimumab Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Belimumab Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Belimumab Revenue in 2020 Figure 26. Belimumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Hospital Figure 28. Global Hospital Sales YoY Growth (2016-2027) & (K Pcs) Figure 29. Product Picture of Drug Center Figure 30. Global Drug Center Sales YoY Growth (2016-2027) & (K Pcs) Figure 31. Product Picture of Clinic Figure 32. Global Clinic Sales YoY Growth (2016-2027) & (K Pcs) Figure 33. Product Picture of Other Figure 34. Global Other Sales YoY Growth (2016-2027) & (K Pcs) Figure 35. Global Belimumab Sales by Application (2016-2027) & (US$ Million) Figure 36. Global Belimumab Sales Market Share in Volume by Application (2016-2021) Figure 37. Global Belimumab Sales Market Share in Value by Application (2016-2021) Figure 38. Global Belimumab Sales Market Share in Volume by Application (2022-2027) Figure 39. North America Belimumab Sales Market Share in Volume by Application in 2020 Figure 40. Latin America Belimumab Sales Market Share in Value by Application in 2020 Figure 41. Middle East and Africa Belimumab Sales Market Share in Value by Application in 2020 Figure 42. Key Raw Materials Price Figure 43. Belimumab Manufacturing Cost Structure Figure 44. Belimumab Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

GlaxoSmithKline